Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$447,466,599
+$67,558,759 QoQ
Shares Held
2,359,807
+22.5% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#59
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $6,780,882,947 across 16 Drug Manufacturers - General names. AZN ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,724,702 | $2,068,659,488 | |
| 2 | JNJ |
Johnson & Johnson
|
4,646,972 | $1,180,191,474 | |
| 3 | ABBV |
AbbVie Inc.
|
3,470,007 | $873,192,557 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,565,728 | $715,196,045 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,772,428 | $476,608,548 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
2,359,807 | $447,466,599 | |
| 7 | AMGN |
Amgen Inc
|
882,230 | $319,473,122 | |
| 8 | GSK |
GSK plc
|
4,042,863 | $211,926,875 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $447,466,599 | 2,359,807 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $379,907,840 | 1,926,315 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||